Annual Drug Patent Expirations for ARNUITY+ELLIPTA
Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
ARNUITY ELLIPTA drug price trends.
Drug patent litigation for ARNUITY ELLIPTA.
This drug has one hundred and two patent family members in twenty-seven countries.
The generic ingredient in ARNUITY ELLIPTA is fluticasone furoate. One supplier is listed for this compound. Additional details are available on the fluticasone furoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
